The dream of a disease free world

Our approach with MicroMTx003 aims to treat Ischemic Heart Disease by leveraging the power of mRNA technology

Ischemic Heart Disease (IHD) also known as Coronary Artery Disease (CAD) occurs when blood flow to the heart is reduced, preventing the heart muscle from receiving enough oxygen. IHD tends to be progressive in nature and worsens over time.

Current Line of Treatment



Daily Medication
  • Life long duration therapy
  • Not very effective
  • Other complications

Significant Worldwide Burden

Annual Cases


126 m

MicroMTx003 is a next-generation mRNA therapeutic that increases the production of a particular protein in the body. This protein is responsible for the growth and development of blood vessels and has regenerative effects on damaged blood vessels and tissue. By increasing the amount of this specific protein produced in the body using MicroMTx003, we can improve the cardiovascular system’s regeneration capabilities and in turn significantly slow down if not completely reverse the progress of IHD in patients.

Check out some of the other next-generation living therapeutics that are being developed by Micro CRISPR.